Antagonism between bacteriostatic and bactericidal antibiotics is prevalent

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Combination antibiotic therapy is underutilized for combating bacterial resistance.
• Understanding drug interactions at inhibitory concentrations is crucial for effective combination therapy.
• A long-standing hypothesis suggests bacteriostatic drugs may antagonize bactericidal drugs by inhibiting bacterial growth.

Purpose of the Study:

• To systematically investigate the hypothesis that bacteriostatic antibiotics antagonize bactericidal antibiotics.
• To characterize drug interactions across various antibiotic classes and concentrations.
• To explore the cellular mechanisms underlying antibiotic combination effects.

Main Methods:

• Construction of time-kill curves for five antibiotics at clinically relevant concentrations.
• Screening of pairwise combinations of 21 antibiotics at subinhibitory concentrations.
• Microfluidic device experiments with time-lapse microscopy to observe individual bacterial cell responses.

Main Results:

• Antagonism was observed between bactericidal and bacteriostatic drugs in time-kill assays.
• Screening revealed a significant enrichment of antagonistic interactions between bacteriostatic and bactericidal drug combinations.
• Single-cell microscopy confirmed antagonism but also showed unexpected diversity in cellular responses.

Conclusions:

• The study provides systematic evidence supporting the antagonism between bacteriostatic and bactericidal antibiotics.
• Antibiotic combination efficacy is influenced by the interplay between drug classes and bacterial growth.
• Diverse cellular mechanisms contribute to the observed antagonistic interactions, warranting further investigation.